The Metricath® System is a patented catheter-based technology that allows interventional cardiologists and radiologists to precisely measure arterial and stent lumen size during interventional treatment of coronary and peripheral artery disease. These measurements assist physicians in their selection and use of interventional devices, such as stents.

The Metricath System uses a compact console unit and a disposable balloon-tipped catheter, which provide significant technical, operational and cost saving advantages over current offerings available on the market. Metricath catheters come in two varieties: Metricath Libra® measure-only catheters and Metricath Gemini® measure-and-treat catheters.

The Metricath System has received FDA clearance for sale in the United States and European CE Mark approval. Feedback from interventional cardiologists, interventional radiologists and vascular surgeons indicates that the Metricath System has the potential to become a “standard of practice” for angioplasty procedures and has particular value in conjunction with the utilization of drug eluting stents.

To see a 3D animation of how the Metricath works, click here.

For more detailed information about the Metricath System, please visit Angiometrx's website at www.angiometrx.com.